Flashworks LC was founded to commercialize innovative technologies for automated dendritic cell generation and T cell production for applications including cell-based immunotherapy and biologics discovery. The important shift to personalized therapies has mean an increase in the demand for Dendritic cells. However, the process for generating Dendritic cells has remained laborious, error-prone, and time intensive. To address this situation, Flaskworks has produced a device, MicroDen, that revolutionizes the process. MicroDen is compact, easy-to-use, efficient, affordable, and 10x more productive than current methods and devices.
